 | Astria Therapeutics, Inc. | |||
| NGM : ATXS || Location: United States | ||||
$10.09-0.45 (-4.32%) |
0.12 M | 10.04 - 10.64 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| March 28, 2024 | 5.060 M |
| March 15, 2024 | 2.013 M |
| Feb. 29, 2024 | 1.697 M |
| Feb. 15, 2024 | 1.962 M |
| Jan. 31, 2024 | 2.047 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 12/31/2023 | -0.80 | -0.94 | -18.12% |
| 09/30/2023 | -0.50 | -0.63 | -27.09% |
| 06/30/2023 | -0.50 | -0.45 | 9.44% |
| 03/31/2023 | -0.56 | -0.40 | 28.94% |
| 12/31/2022 | -0.73 | -0.72 | 0.81% |
ATXS Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 54.903M | Shares Float | 36.139M |
| Short Float | 5.060M | Market Cap | 578.68M |
| Institution ownership | 88.15% | Insider ownership | 0.488% |
| Earnings Date | 05/09/2024 AMC | Cash Per Share | ? |
| Trailing EPS | -2.32 | Forward EPS | -1.74 |